Back to search

France· FR:69644015

ENTECAVIR ACCORD 1 mg, comprimé pelliculé

A entecavir product containing entécavir monohydraté, registered in France by ACCORD HEALTHCARE (ESPAGNE), on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J05AF10

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedENTECAVIR ACCORD 1 mg, comprimé pelli…ATCJ05AF10REGISTER NO.FR:69644015PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Entecavir is registered in 17 of 19 countries.

Countries holding a registration under ATC J05AF10 (entecavir), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose

Entecavir · ATC J05AF10

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of entecavir costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $0.20 in United States to $12.37 in Switzerland — a ×61 gap.

  • France: $7.50 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Entecavir · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$12.37
  • FR France$7.50
  • IT Italy$4.93
  • US United States$0.20 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ENTÉCAVIR MONOHYDRATÉ
Manufacturer
ACCORD HEALTHCARE (ESPAGNE)
Country
France (FR)
ATC code
J05AF10
ATC class
Entecavir
Defined daily dose
0.5 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930118771
    30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s) (dose unitaire)
    EUR 131.7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for entecavir.

Graded by severity as the source publishes them — 56 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Entecavir · interactions on record

56 records

  • 56 moderate

Most severe, free to view

  • CimetidineA02BA01moderate
  • RanitidineA02BA02moderate
  • FamotidineA02BA03moderate
  • NeomycinA07AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Entecavir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All entecavir products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Entecavir Ratiopharm
  • Bulgaria · Ентекавир Pharmascience International Ltd, Ентекавир Зентива
  • Cyprus · Entevirem
  • Czechia · Entecavir Fmk, Entecavir Sandoz
  • Germany · Entecavir Al, Entecavir Amarox
  • Denmark · Edevira, Entecavir Medical Valley
  • Spain · Entecavir Aurovitas, Entecavir Dr. Reddys
  • Finland · Entecavir Stada
  • United Kingdom (Northern Ireland) · Entecavir Accord-Uk, Entecavir Amarox
  • Greece · Edevira, Entecavir Sandoz
  • Hungary · Entecavir Pharmascience International Ltd, Entecavir Teva
  • Iceland · Baraclude, Entecavir Accord
  • Italy · Entecavir Aristo, Entecavir Aurobindo
  • Liechtenstein · Baraclude, Entecavir Accord
  • Lithuania · Entecavir Sandoz
  • Malta · Entecavir Dr. Reddy's, Entecavir Normon
  • Netherlands · Entecavir Amarox, Entecavir Aurobindo
  • Norway · Baraclude, Entecavir Accord
  • Poland · Entecavir Aurovitas, Entecavir Polpharma
  • Portugal · Entecavir Farmoz, Entecavir Generis
  • Romania · Entecavir Labormed, Entecavir Sandoz
  • Sweden · Entecavir Amarox, Entecavir Medical Valley
  • Slovenia · Entekavir Sandoz, Entekavir Stada
  • Slovakia · Entecavir Fmk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cc4616e7-9822-46f2-b882-82876e57be29
GET /v1/drugs/cc4616e7-9822-46f2-b882-82876e57be29?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69644015",
  "date_amm": "2017-09-26",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/17/1211",
  "substance": "ENTÉCAVIR MONOHYDRATÉ",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about entecavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.